Hungarian research could yield breakthrough in Covid-19 treatment

The research coordinated by Professor Péter Bay of Debrecen University focused on Rucaparib, which blocks PARP enzymes and may prove effective in the initial phase of the infection and in fighting inflammatory complications of the disease in its later stages, the statement said.

“We have managed to open the way for a unique therapy that can be applied both in the viral and inflammatory phases of the infection, and which also offers an opportunity to prevent further complications in the viral phase,” the statement quoted senior researcher David Bajusz as saying.

The results of the Hungarian research were recently published in the British Journal of Pharmacology.

read also:

Over 1,000-year-old authentic image of Saint Stephen, Hungary’s founder, on an unexpected relic

Hungarian astronomer discovers previously unknown near-Earth asteroids